Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Multiple Myeloma 70Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma, Mantle-Cell 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 14Leukemia, Myeloid, Acute 14Lymphoma, B-Cell, Marginal Zone 13Lymphoma, Non-Hodgkin 12Recurrence 11Neoplasms, Plasma Cell 10Lymphoma 10Myelodysplastic Syndromes 9Hodgkin Disease 8Neoplasms 7Leukemia 7Burkitt Lymphoma 7Waldenstrom Macroglobulinemia 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, B-Cell 6Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Lymphoma, T-Cell, Peripheral 4Lymphoma, Large-Cell, Immunoblastic 4Astrocytoma 4Smoldering Multiple Myeloma 3Prostatic Neoplasms 3Oligodendroglioma 3Melanoma 3

Interventions

fludarabine phosphate 3sargramostim 2Whole-Body Irradiation 2Mycophenolic Acid 2Cyclosporine 2Cyclophosphamide 2Azacitidine 24-phenylbutyric acid 2tipifarnib 1poly ICLC 1bryostatin 1 1aldesleukin 1Tretinoin 1Thiotepa 1Tetradecanoylphorbol Acetate 1Nivolumab 1Methylprednisolone 1Lenalidomide 1Injections 1Immunologic Techniques 1Granulocyte-Macrophage Colony-Stimulating Factor 1Decitabine 1Cord Blood Stem Cell Transplantation 1Bryostatins 1Biopsy 1Arsenic Trioxide 1Antilymphocyte Serum 14'-thio-arabinofuranosylcytosine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Anemia, Refractory × Lenalidomide × Clear all
NCT00104962 2014-06-11

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
Classical hematology

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡